NonMuscular Invasive Bladder Cancer Reenvisioning Therapeutic Journey from
Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions Kuan-Wei Shih, Wei-Chieh Chen, Ching-Hsin Chang, Ting-En Tai, Jeng-Cheng Wu, Andy C. Huang, Ming-Che Liu 1 Department of Urology, Taipei Medical University Hospital, Taipei 11031, Taiwan. 2 Graduate Institute of Clinical Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. 3 TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 11031, Taiwan. 4 Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 11031, Taiwan. 5 Department of Education, Taipei Medical University Hospital, Taipei 11031, Taiwan. 6 Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. 7 Clinical Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan. 8 Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan. 9 Department of Urology, Department of Surgery, Taipei City Hospital Ren-Ai Branch, Taipei 10629, Taiwan. 10 School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan. Figure 5. Regenerative approaches using biomaterials. Bio-molecules, drugs, stem cells and progenitor cells are entrapped in scaffold and could be used to deliver therapeutic impact at target sites. Further, small intestine is decellularized to produce SIS-ECM, a biomaterial for treatment of NMIBC. SIS-ECM: Small intestinal submucosa extracellular matrix. DOI: 10. 14336/AD. 2020. 1109
- Slides: 1